(Q35885133)

10 August 2017

3 references

25 April 2019

2 August 2019

8 October 2022

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease (English)

1 reference

10 August 2017

2 references

25 April 2019

2 August 2019

1 reference

2 August 2019

3

Werner Poewe

1 reference

10 August 2017

2

Klaus Seppi

1 reference

10 August 2017

1

Eva-Maria Hametner

1 reference

PMC publication ID

3324991

10 August 2017

language of work or name

English

0 references

publication date

15 March 2012

4 references

Clinical Interventions in Aging

10 August 2017

25 April 2019

2 August 2019

8 October 2022

4 references

10 August 2017

25 April 2019

2 August 2019

8 October 2022

7

1 reference

10 August 2017

83-88

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

10 August 2017

start time

1 March 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

A reassessment of risks and benefits of dopamine agonists in Parkinson's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Comparative responsiveness of Parkinson's disease scales to change over time.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Levodopa in the treatment of Parkinson's disease: current controversies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

A systematic review of adherence with medications for diabetes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

The impact of reducing dose frequency on health outcomes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Patient compliance and the conduct and interpretation of therapeutic trials.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Pharmacological profiles and clinical effects of antiparkinsonian agent, pramipexole

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Drug adherence in Parkinson's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Patient compliance with antihypertensive regimens.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3324991

Dose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical Trial

24 September 2018

1 reference

12 December 2020

L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP

1 reference

12 December 2020

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

1 reference

12 December 2020

Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study

1 reference

12 December 2020

Suboptimal medication adherence in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.2147/CIA.S11829

1 reference

10 August 2017

1 reference

PMC publication ID

3324991

10 August 2017

PubMed publication ID

22500116

1 reference

PMC publication ID

3324991